Gedeon Richter
Hungary - BudapestBiotechnology
Focus: Gedeon Richter is a publicly-traded Hungarian pharmaceutical company founded in 1901 with 1,001-5,000 employees, specializing in small-molecule generics and branded drugs across neurology, cardiovascular, metabolic, and immunology markets.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Gedeon Richter
AI assessmentNot HiringNo open roles listed right now. Follow Gedeon Richter to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
11 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Pre-Launch
ANDA generic antifungal in pre-launch phase; standard-of-care agent with established safety profile but limited differentiation.
Help build intelligence for Gedeon Richter
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.